Biomarkers Can Personalize Proactive Retinal Care – A Doctor’s Analysis Biomarkers Can Personalize Proactive Retinal Care In my previous article, I discussed practical functional tests and systemic biomarkers that can be used…
CDC: Kindergarten vaccine exemptions exceed 4% nationwide
Kindergarten Vaccine Exemptions Exceed 4%: A Doctor’s Analysis on Public Health Risk Kindergarten Vaccine Exemptions Exceed 4%: A Doctor’s Analysis on Public Health Risk The Unsettling Trend: Rising Vaccine Exemptions and Public…
FDA approves two autoinjector formulations for Stelara biosimilar
FDA Approves Autoinjector for Stelara Biosimilar: A Leap for Patient Convenience and Access FDA Approves Autoinjector for Stelara Biosimilar: A Leap for Patient Convenience and Access Main Article: Empowering Patients with Enhanced…
Duvakitug shows improved outcomes in ulcerative colitis, Crohn’s
Duvakitug: A New Horizon in Inflammatory Bowel Disease Management Duvakitug: A New Horizon in Inflammatory Bowel Disease Management An investigational anti-TL1A monoclonal antibody achieved “clinically meaningful” outcomes compared with placebo in patients…
Socioeconomics sway exercise benefits in those with breast cancer
Socioeconomics Sway Exercise Benefits in Those with Breast Cancer: A Physician’s Perspective Socioeconomics Sway Exercise Benefits in Those with Breast Cancer: A Physician’s Perspective Summary: Research indicates that postmenopausal women with breast…
Q&A: Frozen ‘poop pills’ may treat peanut allergy in adults
A Doctor’s Perspective: Unpacking the Potential of “Poop Pills” for Peanut Allergy The Gut-Brain-Allergy Axis: A Doctor’s Take on “Poop Pills” for Peanut Allergy Main Article: A Glimmer of Hope in Peanut…
Azithromycin favored for protecting against COPD exacerbations
Azithromycin: A Strong Contender for Preventing COPD Exacerbations Azithromycin: A Strong Contender for Preventing COPD Exacerbations As a pulmonologist, I constantly seek clearer guidance in managing Chronic Obstructive Pulmonary Disease (COPD), particularly…
A PCP’s perspective on the role of GLP-1 medications
A PCP’s perspective on the role of GLP-1 medications A PCP’s perspective on the role of GLP-1 medications GLP-1 receptor agonists are among the most innovative and transformative medications to come on…
Tirzepatide may not raise risk for diabetic retinopathy
Tirzepatide and Diabetic Retinopathy: Reassuring Signals for Type 1 Diabetes Patients Tirzepatide and Diabetic Retinopathy: Reassuring Signals for Type 1 Diabetes Patients An analysis by [Your Name/Medical Doctor Persona] Recent data from…
Physician reliability increased for gait analysis interpretation
Physician Reliability in Gait Analysis Interpretation: A New Era for Objective Pediatric Care Physician Reliability in Gait Analysis Interpretation: A New Era for Objective Pediatric Care In the complex landscape of pediatric…
Treatment to lower blood pressure reduces recurrent stroke risk
Intensive Blood Pressure Control: A Game Changer in Post-ICH Stroke Prevention Intensive Blood Pressure Control: A Game Changer in Post-ICH Stroke Prevention By Dr. Anya Sharma, MD | October 26, 2023 Main…
Interventional glaucoma takes the lead for vision preservation
Interventional Glaucoma: A Paradigm Shift for Sustainable Vision Preservation Interventional Glaucoma: A Paradigm Shift for Sustainable Vision Preservation This analysis is inspired by the recent insights highlighted in the Healio Exclusive, “Interventional…
ACC issues expert consensus pathway for HFpEF care
Navigating the Evolving Landscape: ACC’s Updated HFpEF Pathway Reshapes Care Navigating the Evolving Landscape: ACC’s Updated HFpEF Pathway Reshapes Care As clinicians on the front lines, we constantly strive to deliver the…
Virtual smoking cessation program benefits patients with cancer
Revolutionizing Cancer Care: The Power of Virtual Smoking Cessation Programs Revolutionizing Cancer Care: The Power of Virtual Smoking Cessation Programs As medical professionals, we continually seek innovative strategies to enhance patient care…
GLP-1 reduces rates of post-bariatric hypoglycemia
Avexitide’s Breakthrough: A Targeted Approach to Post-Bariatric Hypoglycemia Avexitide’s Breakthrough: A Targeted Approach to Post-Bariatric Hypoglycemia A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults…